Current Colorectal Cancer Reports

, Volume 1, Issue 2, pp 110–116 | Cite as

Cancer screening guidelines and prevention factors for high-risk patients with a family history of colorectal cancer

  • Patrick M. Lynch


Family history of colorectal cancer or of adenomas may confer significant risk of colorectal cancer. Ideally, diagnosis of an inherited syndrome such as familial adenomatous polyposis (FAP) or hereditary nonpolyposis colorectal cancer (HNPCC) enables a molecular biology-driven approach to screening and management. When no hereditary syndrome can be established, clinicians must rely on empiric risk estimates and offer screening accordingly. Detailed rationale and guidelines for use of syndrome characteristics including genetic testing, counseling, and selection of surveillance tools are discussed.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Cummings JH, Bingham SA: Diet and the prevention of cancer. BMJ 1998, 317:1636–1640.PubMedGoogle Scholar
  2. 2.
    US Preventive Services Task Force: Guide to Clinical Preventive Services: Report of the US Preventive Services Task Force, edn 2. Baltimore: Williams & Wilkins; 1996.Google Scholar
  3. 3.
    Tomeo CA, Colditz GA, Willett WC, et al.: Harvard report on cancer prevention, vol 3: prevention of colon cancer in the United States. Cancer Causes Control 1999, 10:167–180.PubMedCrossRefGoogle Scholar
  4. 4.
    Smith RA, Cokkinides V, Eyre HJ: American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2005, 55:31–44.PubMedCrossRefGoogle Scholar
  5. 5.
    Selby JV, Friedman GD, Quesenberry CP Jr, et al.: A casecontrol study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992, 326:653–657.PubMedCrossRefGoogle Scholar
  6. 6.
    Newcomb PA, Norfleet RG, Storer BE, et al.: Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992, 84:1572–1575.PubMedCrossRefGoogle Scholar
  7. 7.
    Berry DP, Clarke P, Hardcastle JD, Vellacott KD: Randomized trial of the addition of flexible sigmoidoscopy to faecal occult blood testing for colorectal neoplasia population screening. Br J Surg 1997, 84:1274–1276.PubMedCrossRefGoogle Scholar
  8. 8.
    Vernon S: Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1997, 89:1406–1422.PubMedCrossRefGoogle Scholar
  9. 9.
    Lieberman DA, Weiss DG, Bond JH, et al.: Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000, 343:162–168.PubMedCrossRefGoogle Scholar
  10. 10.
    Winawer S, Fletcher R, Rex D, et al.: Colorectal cancer screening and surveillance: clinical guidelines and rationale- Update based on new evidence. Gastroenterology 2003, 124:544–560.PubMedCrossRefGoogle Scholar
  11. 11.
    Groden J, Thliveris A, Samowitz W, et al.: Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991, 66:589–600.PubMedCrossRefGoogle Scholar
  12. 12.
    Kinzler KW, Nilbert MC, Su LK, et al.: Identification of FAP locus genes from chromosome 5q21. Science 1991, 253:661–665.PubMedCrossRefGoogle Scholar
  13. 13.
    Giardiello FM, Brensinger JD, Tersmette AC, et al.: Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000, 119:1447–1453.PubMedCrossRefGoogle Scholar
  14. 14.
    Howe JR, Mitros FA, Summers RW: The risk of gastrointestinal carcinoma in familial juvenile polyposis. Ann Surg Oncol 1995, 5:751–756.CrossRefGoogle Scholar
  15. 15.
    Rashid A, Houlihan PS, Booker S, et al.: Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology 2000, 119:323–332.PubMedCrossRefGoogle Scholar
  16. 16.
    Leppert M, Burt R, Hughes JP, et al.: Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. N Engl J Med 1990, 322:904–908.PubMedCrossRefGoogle Scholar
  17. 17.
    Spirio L, Olschwang S, Groden J, et al.: Alleles of the APC gene: an attenuated form of familial polyposis. Cell 1993, 75:951–957.PubMedCrossRefGoogle Scholar
  18. 18.
    Al-Tassan N, Chmiel NH, Maynard J, et al.: Inherited variants of MYH associated with somatic G:C--> T:A mutations in colorectal tumors. Nat Genet 2002, 30:227–232.PubMedCrossRefGoogle Scholar
  19. 19.
    Berk T, Cohen Z, Bapat B, et al.: Negative genetic test result in familial adenomatous polyposis: clinical screening implications. Dis Colon Rectum 1999, 42:307–310; discussion 310-312.PubMedCrossRefGoogle Scholar
  20. 20.
    Petersen GM, Slack J, Nakamura Y: Screening guidelines and premorbid diagnosis of familial adenomatous polyposis using linkage. Gastroenterology 1991, 100:1658–1664.PubMedGoogle Scholar
  21. 21.
    Bülow S, Bülow C, Nielsen TF, et al.: Centralized registration, prophylactic examination, and treatment results in improved prognosis in familial adenomatous polyposis. Results from the Danish Polyposis Register. Scand J Gastroenterol 1995, 30:989–993.PubMedGoogle Scholar
  22. 22.
    Church J, Burke C, McGannon E, et al.: Risk of rectal cancer in patients after colectomy and ileorectal anastomosis for familial adenomatous polyposis: a function of available surgical options. Dis Colon Rectum 2003, 46:1175–1181.PubMedCrossRefGoogle Scholar
  23. 23.
    Bülow S, Björk J, Christensen IJ, et al.: Duodenal adenomatosis in familial adenomatous polyposis. Gut 2004, 53:381–386.PubMedCrossRefGoogle Scholar
  24. 24.
    Hawk E, Umar A, Viner JL: Colorectal cancer chemoprevention —an overview of the science. Gastroenterology 2004, 126:1423–1447.PubMedCrossRefGoogle Scholar
  25. 25.
    Vasen HF, Offerhaus GJ, den Hartog Jager FC, et al.: The tumour spectrum in hereditary non-polyposis colorectal cancer: a study of 24 kindreds in the Netherlands. Int J Cancer 1990, 46:31–34.PubMedCrossRefGoogle Scholar
  26. 26.
    Aarnio M, Mecklin JP, Aaltonen LA, et al.: Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995, 64:430–433.PubMedCrossRefGoogle Scholar
  27. 27.
    Watson P, Vasen HF, Mecklin JP, et al.: The risk of endometrial cancer in hereditary nonpolyposis colorectal cancer. Am J Med 1994, 96:516–520.PubMedCrossRefGoogle Scholar
  28. 28.
    Hamilton SR, Liu B, Parsons RE, et al.: The molecular basis of Turcot’s syndrome. N Engl J Med 1995, 332:839–847.PubMedCrossRefGoogle Scholar
  29. 29.
    Lynch HT, Lynch PM, Pester J, et al.: The cancer family syndrome. Rare cutaneous phenotypic linkage of Torre’s syndrome. Arch Intern Med 1981, 141:607–611.PubMedCrossRefGoogle Scholar
  30. 30.
    Vasen HF, Mecklin JP, Khan PM, et al.: The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991, 34:424–425.PubMedCrossRefGoogle Scholar
  31. 31.
    Vasen HF, Watson P, Mecklin JP, et al.: New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999, 116:1453–1456.PubMedCrossRefGoogle Scholar
  32. 32.
    Cao Y, Pieretti M, Marshall J, et al.: Challenge in the differentiation between attenuated familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer: case report with review of the literature. Am J Gastroenterol 2002, 97:1822–1827.PubMedCrossRefGoogle Scholar
  33. 33.
    Aaltonen LA, Salovaara R, Kristo P, et al.: Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 1998, 338:1481–1487.PubMedCrossRefGoogle Scholar
  34. 34.
    Peltomaki P, Aaltonen LA, Sistonen P, et al.: Genetic mapping of a locus predisposing to human coorectal cancer. Science 1993, 260:810–812.PubMedCrossRefGoogle Scholar
  35. 35.
    Leach FS, Nicolaides NC, Papadopoulos N, et al.: Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993, 75:1215–1225.PubMedCrossRefGoogle Scholar
  36. 36.
    Marra G, Boland CR: Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 1995, 87:1114–1125.PubMedCrossRefGoogle Scholar
  37. 37.
    Papadopoulos N, Nicolaides NC, Wei YF, et al.: Mutation of a mutL homolog in hereditary colon cancer. Science 1994, 263:1625–1629.PubMedCrossRefGoogle Scholar
  38. 38.
    Miyaki M, Konishi M, Tanaka K, et al.: Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer. Nat Genet 1997, 17:271–2.PubMedCrossRefGoogle Scholar
  39. 39.
    Nicolaides NC, Papadopoulos N, Liu B, et al.: Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994, 371:75–80.PubMedCrossRefGoogle Scholar
  40. 40.
    Aaltonen LA, Peltomäki P, Leach FS, et al.: Clues to the pathogenesis of familial colorectal cancer. Science 1993, 260:812–816.PubMedCrossRefGoogle Scholar
  41. 41.
    Umar A, Boland CR, Terdiman JP, et al.: Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004, 96:261–268.PubMedCrossRefGoogle Scholar
  42. 42.
    Thibodeau SN, French AJ, Roche PC, et al.: Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996, 56:4836–4340.PubMedGoogle Scholar
  43. 43.
    Lindor NM, Burgart LJ, Leontovich O, et al.: Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002, 20:1043–1048.PubMedCrossRefGoogle Scholar
  44. 44.
    Jass JR, Stewart SJ, Lane MR: Hereditary non-polyposis colorectal cancer -morphologies, genes and mutations. Mutation Research 1994, 310:125–133.PubMedGoogle Scholar
  45. 45.
    Syngal S, Fox EA, Li C, et al.: Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing. JAMA 1999, 282:247–253.PubMedCrossRefGoogle Scholar
  46. 46.
    American Society of Human Genetics: ASHG Statement: professional disclosure of familial genetic information. Am J Hum Genet 1999, 62:474–483.CrossRefGoogle Scholar
  47. 47.
    Gritz ER, Peterson SK, Vernon SW, et al.: Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2005, 23:1902–1910.PubMedCrossRefGoogle Scholar
  48. 48.
    Wang Y, Friedl W, Lamberti C, et al.: Hereditary nonpolyposis colorectal cancer: frequent occurrence of large genomic deletions in MSH2 and MLH1 genes. Int J Cancer 2003, 103:636–641.PubMedCrossRefGoogle Scholar
  49. 49.
    Järvinen HJ, Aarnio M, Mustonen H, et al.: Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 2000, 118:829–834.PubMedCrossRefGoogle Scholar
  50. 50.
    Burke W, Petersen G, Lynch P, et al.: Recommendations for follow- up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium. JAMA 1997, 277:915–919.PubMedCrossRefGoogle Scholar
  51. 51.
    Vasen HF, den Hartog Jager FC, Menko FH, et al.: Screening for hereditary non-polyposis colorectal cancer: a study of 22 kindreds in The Netherlands. Am J Med 1989, 86:278–281.PubMedCrossRefGoogle Scholar
  52. 52.
    Rijcken FEM, Hollema H, Kleibeuker JH: Proximal adenomas in hereditary non-polyposis colorectal cancer are prone to rapid malignant transformation. Gut 2002, 50:382–386.PubMedCrossRefGoogle Scholar
  53. 53.
    Kiesslich R, Jung M, DiSario JA, Galle PR, Neurath MF: Perspectives of chromo and magnifying endoscopy: how, how much, when, and whom should we stain. Clin Gastro 2004, 38:7–13.CrossRefGoogle Scholar
  54. 54.
    De Jong AE, Morreau H, Van Puijenbroek M, et al.: The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. Gastroenterology 2004, 126:42–48.PubMedCrossRefGoogle Scholar
  55. 55.
    Winawer SJ, Zauber AG, Ho MN, et al.: Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. N Engl J Med 1993, 329:1977–1981.PubMedCrossRefGoogle Scholar
  56. 56.
    Citarda F, Tomaselli G, Capocaccia R, et al.: Efficacy in standard clinical practice of colonoscopic polypectomy in reducing colorectal cancer incidence. Gut 2001, 48:812–815.PubMedCrossRefGoogle Scholar
  57. 57.
    Ahmad NA, Kochman ML, Long WB, et al.: Efficacy, safety, and clinical outcomes of endoscopic mucosal resection: a study of 101 cases. Gastrointest Endosc 2002, 55:390–396.PubMedCrossRefGoogle Scholar
  58. 58.
    Fuchs CS, Giovannucci EL, Colditz GA, et al.: A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994, 331:1669–1674.PubMedCrossRefGoogle Scholar
  59. 59.
    Winawer SJ, Zauber AG, Gerdes H, et al.: Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med 1996, 334:82–87.PubMedCrossRefGoogle Scholar
  60. 60.
    NCCN Clinical Practice Guidelines In Oncology. This is a current detailed algorithm for evaluation and screening of patients with FAP, HNPCC, and a positive family history.Google Scholar
  61. 61.
    PDQ - NCI’s Comprehensive Cancer Database, Genetics Summaries Of Colorectal Cancer. cancertopics/pdq/cancerdatabase This is a current comprehensive evidence-based review of literature on FAP, HNPCC, and familial colon cancer.Google Scholar

Copyright information

© Current Science Inc. 2005

Authors and Affiliations

  • Patrick M. Lynch
    • 1
  1. 1.Department of Gastrointestinal Medicine and Nutrition-436The University of Texas M.D. Anderson Cancer CenterHoustonUSA

Personalised recommendations